Neural mechanisms of ASH1L in autism spectrum disorder
ASH1L 在自闭症谱系障碍中的神经机制
基本信息
- 批准号:10725205
- 负责人:
- 金额:$ 41.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2025-07-14
- 项目状态:未结题
- 来源:
- 关键词:ASD patientASH1L geneAcetylcholineAddressAffectAttentionAutomobile DrivingAutopsyBrainBrain regionCHRM1 geneChildCholine O-AcetyltransferaseCholinergic ReceptorsCognitionCuesDataDetectionEnzymesFDA approvedFemaleGeneticGenetic studyGoalsHumanHuman GeneticsImpairmentIndividualKnock-outLabelMeasuresMediatingMessenger RNAMusNeuromodulatorNicotinic ReceptorsOutputPathway interactionsPatientsPharmaceutical PreparationsPhenotypePlayPrefrontal CortexRoleSignal TransductionSliceSocial BehaviorSocial InteractionStimulusSymptomsSynapsesSystemTNFSF5 geneTechniquesTestingTherapeuticTherapeutic Interventionautism spectrum disorderautistic childrenbasal forebrainbrain tissuecholinergiccholinergic neurongenetic technologygoal oriented behaviorhigh riskhistone methyltransferasehuman modelin vivoinsightloss of function mutationmalemouse modelneuralneural circuitneuromechanismnoveloptogeneticspharmacologicrisk variantsocialsocial deficitstherapeutic developmenttherapeutic evaluationtooltransmission process
项目摘要
Project Summary/Abstract
Neural mechanisms of ASH1L in autism spectrum disorder
Social deficits are the core phenotypes of children with autism spectrum disorder (ASD). One important but
unresolved question is the neural mechanisms driving social deficits. Human genetic studies have identified
histone methyltransferase ASH1L as a high-risk gene for ASD. We have found that Ash1l haploinsufficiency
mice displayed social deficits, which recapitulated the core symptoms in ASD patients. The goal of this proposal
is to determine the neural circuits driving ASH1L haploinsufficiency-associated social deficits. Pioneering studies
have shown that neuromodulator acetylcholine plays an essential role in attention and cognition. Cholinergic
neurons in the basal forebrain (BF) are the major acetylcholine output to the downstream regions such as
prefrontal cortex (PFC), a key brain region involved in social behavior and impaired in children with ASD.
However, it is unknown which if any of cholinergic projections play a causal role in ASH1L haploinsufficiency-
associated social deficits. We hypothesize that impaired cholinergic circuits from BF drive social deficits in Ash1l
haploinsufficiency mice. To test this, we will use combination of cutting-edge techniques to address two Specific
Aims: (1) To determine diminished cholinergic neuronal activity in the BF driving social deficits in Ash1l
haploinsufficiency mice. Brain slices recording, in vivo multichannel recordings and chemogenetic technology
will be used to examine the cholinergic neuronal activity in the BF at cellular and in vivo levels. (2) To determine
cholinergic neural circuits from BF mediating social deficits in Ash1l haploinsufficiency mice. By combining
optogenetic and chemogenetic tools to manipulate cholinergic neuronal activity, we will examine specific
cholinergic transmission from BF to PFC in Ash1l haploinsufficiency mice at circuit level. This proposal will
address important neural underpinnings of ASD-associated social deficits. The results from this project will
provide a novel cholinergic circuit driving ASH1L haploinsufficiency-related social deficits, and shed new light on
the development of therapeutic interventions for ASD children by activation of cholinergic system.
项目摘要/摘要
自闭症谱系障碍中ASH1L的神经机制
社会缺陷是自闭症谱系障碍儿童(ASD)的核心表型。一个重要的,但是
未解决的问题是驱动社会缺陷的神经机制。人类遗传研究已经确定
组蛋白甲基转移酶ASH1L作为ASD的高风险基因。我们发现ASH1L单倍弥补
小鼠表现出社会缺陷,从而概括了ASD患者的核心症状。该提议的目标
是为了确定驱动ASH1L单倍弥补相关的社会缺陷的神经回路。开创性研究
已经表明,神经调节剂乙酰胆碱在注意力和认知中起着至关重要的作用。胆碱能
基础前脑(BF)中的神经元是向下游区域的主要乙酰胆碱输出
前额叶皮层(PFC),这是参与社会行为的关键大脑区域,并在ASD儿童中受损。
但是,尚不清楚的是,如果任何胆碱能预测在ASH1L单倍度不足 -
相关的社会缺陷。我们假设BF Drive社会缺陷中ASH1L的胆碱能电路受损
单倍性小鼠。为了测试这一点,我们将使用尖端技术的组合来解决两个特定的
目的:(1)确定在BF驱动社会缺陷中胆碱能神经元活动减少的目标
单倍性小鼠。大脑切片记录,体内多通道记录和化学遗传技术
将用于检查BF在细胞和体内水平的BF中的胆碱能神经元活性。 (2)确定
来自BF的胆碱能神经回路介导了ASH1L单倍不足小鼠的社会缺陷。通过组合
操纵胆碱能神经元活性的光遗传学和化学遗传学工具,我们将检查特定
在电路水平的ASH1L单倍不足小鼠中,从BF到PFC的胆碱能传播。该提议将
解决与ASD相关的社会缺陷的重要神经基础。这个项目的结果将
提供一种新颖
通过激活胆碱能系统为ASD儿童开发治疗性干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luye Qin其他文献
Luye Qin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
抽动秽语综合征易感基因ASH1L突变遗传学及其介导纹状体直接与间接通路调控失衡的致病机制研究
- 批准号:82371546
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
组蛋白甲基转移酶Ash1l通过调节Stac2基因表达影响破骨分化的作用及机制研究
- 批准号:82100945
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
组蛋白甲基转移酶Ash1l通过调节Stac2基因表达影响破骨分化的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tourette综合征新易感基因ASH1L遗传学验证及其突变影响多巴胺代谢异常的机制研究
- 批准号:82001441
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
ASH1L基因参与的神经发育与功能疾病机制研究
- 批准号:31970903
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Epigenetic mechanisms of histone methyltransferase ASH1L in autism spectrum disorder
组蛋白甲基转移酶 ASH1L 在自闭症谱系障碍中的表观遗传机制
- 批准号:
10743048 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
ASH1L mediated transcription networks in autism spectrum disorders
自闭症谱系障碍中 ASH1L 介导的转录网络
- 批准号:
10733409 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
ASH1L mediated transcription networks in autism spectrum disorders
自闭症谱系障碍中 ASH1L 介导的转录网络
- 批准号:
10819810 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
The role of H3K36 methyltransferases on non-CpG methylation patterning in the mammalian brain
H3K36 甲基转移酶对哺乳动物大脑非 CpG 甲基化模式的作用
- 批准号:
10535544 - 财政年份:2022
- 资助金额:
$ 41.11万 - 项目类别:
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
加速组蛋白赖氨酸甲基化调节剂药物开发的分子工具箱
- 批准号:
10481092 - 财政年份:2022
- 资助金额:
$ 41.11万 - 项目类别: